Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism QPCT modulators(Glutaminyl-peptide cyclotransferase modulators), QPCTL modulators(glutaminyl-peptide cyclotransferase like modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization 858 Therapeutics, Inc.Startup |
Active Organization 858 Therapeutics, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Immune System Diseases | Preclinical | US | 858 Therapeutics, Inc.Startup | 01 Oct 2024 |
Atherosclerosis | Preclinical | US | 858 Therapeutics, Inc.Startup | 29 May 2024 |
Neurodegenerative Diseases | Preclinical | US | 858 Therapeutics, Inc.Startup | 29 May 2024 |